He specializes in financial planning, audit, compliance and ERP implementation, with extensive experience in leading automation and risk management projects
The company has posted net profit) of Rs.18.88 crores for the Financial Year ended March 31, 2024
Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023
The company has reported total income of Rs. 79.33 crores during the period ended December 31, 2022
The company has reported total income of Rs. 77.60 crores during the period ended September 30, 2022
It is expected that the drug substance would be available from August 2021 which will be supplied back to Bharat Biotech for producing COVAXIN
In animal health, the products will be mainly targeting mastitis and production disorders, gastrointestinal tract diseases, reproductive disorders, ectoparasites, and skin injuries
Subscribe To Our Newsletter & Stay Updated
